These two authors contributed equally to this work.
Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A
Article first published online: 12 MAR 2007
Copyright © 2007 Wiley-Liss, Inc.
International Journal of Cancer
Volume 121, Issue 1, pages 199–205, 1 July 2007
How to Cite
Müller, C. R., Paulsen, E. B., Noordhuis, P., Pedeutour, F., Sæter, G. and Ola Myklebost (2007), Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A. Int. J. Cancer, 121: 199–205. doi: 10.1002/ijc.22643
- Issue published online: 24 APR 2007
- Article first published online: 12 MAR 2007
- Manuscript Accepted: 18 JAN 2007
- Manuscript Received: 13 SEP 2006
- The FUGE programe of the Norwegian Research Council, Norwegian Foundation for Health and Rehabilitation
- Norwegian Cancer Society
- Comité des Alpes-Maritimes de la Ligue Nationale Contre le Cancer
|jws-ijc.22643.doc||345K||Supporting Information file jws-ijc.22643.doc|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.